Kazakhstan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.26 (1.85 - 2.57) 2019 Modelled IHME
2.36 (1.99 - 2.68) 2018 Modelled IHME
2.42 (2.05 - 2.78) 2017 Modelled IHME
2.43 (2.04 - 2.76) 2016 Modelled IHME
2.44 (2.02 - 2.80) 2015 Modelled IHME
2.48 (2.07 - 2.84) 2014 Modelled IHME
2.57 (2.17 - 2.93) 2013 Modelled IHME
2.68 (2.29 - 3.04) 2012 Modelled IHME
2.79 (2.39 - 3.17) 2011 Modelled IHME
2.88 (2.45 - 3.32) 2010 Modelled IHME
2.95 (2.52 - 3.38) 2009 Modelled IHME
3.02 (2.57 - 3.46) 2008 Modelled IHME
3.08 (2.61 - 3.55) 2007 Modelled IHME
3.14 (2.63 - 3.66) 2006 Modelled IHME
3.21 (2.67 - 3.76) 2005 Modelled IHME
3.28 (2.73 - 3.80) 2004 Modelled IHME
3.36 (2.80 - 3.85) 2003 Modelled IHME
3.44 (2.87 - 3.94) 2002 Modelled IHME
3.51 (2.93 - 4.06) 2001 Modelled IHME
3.58 (2.98 - 4.19) 2000 Modelled IHME
3.66 (3.07 - 4.23) 1999 Modelled IHME
3.75 (3.14 - 4.30) 1998 Modelled IHME
3.83 (3.23 - 4.38) 1997 Modelled IHME
3.89 (3.28 - 4.46) 1996 Modelled IHME
3.91 (3.30 - 4.52) 1995 Modelled IHME
3.91 (3.27 - 4.50) 1994 Modelled IHME
3.9 (3.26 - 4.47) 1993 Modelled IHME
3.87 (3.25 - 4.44) 1992 Modelled IHME
3.83 (3.18 - 4.41) 1991 Modelled IHME
3.77 (3.09 - 4.36) 1990 Modelled IHME
1.57 (1.22 - 2.05) 2015 Modelled WHO
2.7 (1.90 - 3.60) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.22 (0.17 - 0.28) 2019 Modelled IHME
0.23 (0.18 - 0.29) 2018 Modelled IHME
0.24 (0.18 - 0.30) 2017 Modelled IHME
0.26 (0.19 - 0.32) 2016 Modelled IHME
0.27 (0.20 - 0.35) 2015 Modelled IHME
0.27 (0.20 - 0.34) 2014 Modelled IHME
0.26 (0.19 - 0.33) 2013 Modelled IHME
0.25 (0.18 - 0.32) 2012 Modelled IHME
0.25 (0.17 - 0.32) 2011 Modelled IHME
0.25 (0.17 - 0.32) 2010 Modelled IHME
0.25 (0.17 - 0.31) 2009 Modelled IHME
0.25 (0.18 - 0.31) 2008 Modelled IHME
0.25 (0.18 - 0.31) 2007 Modelled IHME
0.25 (0.19 - 0.31) 2006 Modelled IHME
0.25 (0.19 - 0.31) 2005 Modelled IHME
0.27 (0.21 - 0.33) 2004 Modelled IHME
0.32 (0.24 - 0.39) 2003 Modelled IHME
0.39 (0.29 - 0.48) 2002 Modelled IHME
0.48 (0.35 - 0.61) 2001 Modelled IHME
0.59 (0.43 - 0.75) 2000 Modelled IHME
0.94 (0.70 - 1.19) 1999 Modelled IHME
1.61 (1.22 - 2.01) 1998 Modelled IHME
2.37 (1.81 - 2.95) 1997 Modelled IHME
2.99 (2.30 - 3.71) 1996 Modelled IHME
3.24 (2.49 - 4.06) 1995 Modelled IHME
3.24 (2.50 - 4.04) 1994 Modelled IHME
3.22 (2.49 - 3.99) 1993 Modelled IHME
3.18 (2.43 - 3.96) 1992 Modelled IHME
3.09 (2.33 - 3.86) 1991 Modelled IHME
2.94 (2.17 - 3.73) 1990 Modelled IHME
0.21 (0.14 - 0.32) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
616,275 (505,147 - 713,947) 1990 Modelled IHME
624,053 (518,586 - 718,577) 1991 Modelled IHME
626,371 (524,990 - 717,325) 1992 Modelled IHME
624,432 (522,751 - 715,241) 1993 Modelled IHME
619,385 (517,217 - 711,935) 1994 Modelled IHME
612,453 (515,815 - 706,654) 1995 Modelled IHME
601,551 (506,486 - 689,479) 1996 Modelled IHME
585,899 (493,620 - 669,182) 1997 Modelled IHME
568,362 (476,415 - 651,124) 1998 Modelled IHME
551,546 (462,243 - 637,186) 1999 Modelled IHME
537,805 (447,796 - 627,956) 2000 Modelled IHME
526,482 (439,599 - 609,154) 2001 Modelled IHME
515,826 (431,415 - 591,495) 2002 Modelled IHME
506,057 (422,467 - 580,112) 2003 Modelled IHME
497,438 (413,120 - 575,482) 2004 Modelled IHME
490,237 (406,966 - 574,199) 2005 Modelled IHME
484,591 (405,928 - 563,852) 2006 Modelled IHME
480,095 (407,034 - 552,819) 2007 Modelled IHME
476,150 (405,513 - 545,291) 2008 Modelled IHME
472,082 (403,103 - 540,252) 2009 Modelled IHME
467,036 (397,661 - 538,506) 2010 Modelled IHME
458,700 (392,584 - 521,000) 2011 Modelled IHME
446,655 (381,059 - 507,416) 2012 Modelled IHME
434,426 (367,087 - 494,770) 2013 Modelled IHME
425,850 (354,668 - 487,263) 2014 Modelled IHME
424,522 (351,798 - 488,474) 2015 Modelled IHME
429,198 (361,112 - 487,961) 2016 Modelled IHME
433,576 (366,599 - 498,005) 2017 Modelled IHME
429,240 (362,091 - 486,716) 2018 Modelled IHME
415,171 (339,925 - 473,554) 2019 Modelled IHME
479,000 (336,000 - 645,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.27 (5.27 - 9.83) 2019 Modelled IHME
7.38 (5.39 - 9.80) 2018 Modelled IHME
7.46 (5.54 - 9.76) 2017 Modelled IHME
7.66 (5.77 - 10.10) 2016 Modelled IHME
7.87 (5.95 - 10.40) 2015 Modelled IHME
8.18 (6.19 - 10.60) 2014 Modelled IHME
8.59 (6.53 - 11.20) 2013 Modelled IHME
9.25 (7.10 - 11.90) 2012 Modelled IHME
9.27 (7.10 - 11.90) 2011 Modelled IHME
9.14 (7.06 - 11.80) 2010 Modelled IHME
9.36 (7.21 - 11.90) 2009 Modelled IHME
10.6 (8.23 - 13.10) 2008 Modelled IHME
12 (9.40 - 14.90) 2007 Modelled IHME
12.7 (10 - 15.70) 2006 Modelled IHME
12.6 (10 - 15.40) 2005 Modelled IHME
12 (9.51 - 14.60) 2004 Modelled IHME
11.5 (9.21 - 14) 2003 Modelled IHME
10.8 (8.74 - 13) 2002 Modelled IHME
10.3 (8.31 - 12.40) 2001 Modelled IHME
9.84 (8.01 - 11.80) 2000 Modelled IHME
9.47 (7.70 - 11.50) 1999 Modelled IHME
9.44 (7.71 - 11.30) 1998 Modelled IHME
9.5 (7.77 - 11.40) 1997 Modelled IHME
9.36 (7.68 - 11.30) 1996 Modelled IHME
8.8 (7.15 - 10.70) 1995 Modelled IHME
7.94 (6.47 - 9.56) 1994 Modelled IHME
7.11 (5.80 - 8.57) 1993 Modelled IHME
6.17 (5 - 7.41) 1992 Modelled IHME
5.43 (4.39 - 6.51) 1991 Modelled IHME
4.72 (3.78 - 5.70) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,337 (969 - 1,809) 2019 Modelled IHME
1,340 (979 - 1,781) 2018 Modelled IHME
1,337 (992 - 1,749) 2017 Modelled IHME
1,353 (1,020 - 1,779) 2016 Modelled IHME
1,371 (1,036 - 1,807) 2015 Modelled IHME
1,404 (1,062 - 1,827) 2014 Modelled IHME
1,453 (1,104 - 1,896) 2013 Modelled IHME
1,543 (1,183 - 1,988) 2012 Modelled IHME
1,525 (1,168 - 1,963) 2011 Modelled IHME
1,481 (1,144 - 1,910) 2010 Modelled IHME
1,496 (1,153 - 1,903) 2009 Modelled IHME
1,666 (1,298 - 2,071) 2008 Modelled IHME
1,872 (1,464 - 2,323) 2007 Modelled IHME
1,959 (1,543 - 2,417) 2006 Modelled IHME
1,927 (1,531 - 2,344) 2005 Modelled IHME
1,819 (1,440 - 2,216) 2004 Modelled IHME
1,725 (1,388 - 2,106) 2003 Modelled IHME
1,619 (1,312 - 1,951) 2002 Modelled IHME
1,543 (1,245 - 1,858) 2001 Modelled IHME
1,476 (1,202 - 1,772) 2000 Modelled IHME
1,426 (1,159 - 1,729) 1999 Modelled IHME
1,431 (1,169 - 1,715) 1998 Modelled IHME
1,452 (1,187 - 1,745) 1997 Modelled IHME
1,447 (1,187 - 1,751) 1996 Modelled IHME
1,378 (1,119 - 1,668) 1995 Modelled IHME
1,257 (1,025 - 1,514) 1994 Modelled IHME
1,138 (929 - 1,373) 1993 Modelled IHME
997 (809 - 1,198) 1992 Modelled IHME
884 (716 - 1,061) 1991 Modelled IHME
772 (619 - 934) 1990 Modelled IHME
3,273 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (17 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (16 - 31) 2017 Modelled IHME
23 (17 - 31) 2016 Modelled IHME
23 (17 - 31) 2015 Modelled IHME
23 (17 - 31) 2014 Modelled IHME
23 (17 - 31) 2013 Modelled IHME
23 (17 - 31) 2012 Modelled IHME
23 (17 - 31) 2011 Modelled IHME
24 (17 - 31) 2010 Modelled IHME
24 (17 - 32) 2009 Modelled IHME
24 (18 - 32) 2008 Modelled IHME
25 (19 - 33) 2007 Modelled IHME
26 (19 - 34) 2006 Modelled IHME
26 (19 - 34) 2005 Modelled IHME
26 (19 - 34) 2004 Modelled IHME
26 (19 - 35) 2003 Modelled IHME
27 (19 - 35) 2002 Modelled IHME
27 (20 - 36) 2001 Modelled IHME
27 (20 - 36) 2000 Modelled IHME
27 (20 - 36) 1999 Modelled IHME
27 (20 - 36) 1998 Modelled IHME
27 (20 - 36) 1997 Modelled IHME
27 (20 - 37) 1996 Modelled IHME
27 (20 - 37) 1995 Modelled IHME
27 (20 - 37) 1994 Modelled IHME
27 (20 - 36) 1993 Modelled IHME
27 (20 - 36) 1992 Modelled IHME
26 (19 - 35) 1991 Modelled IHME
25 (19 - 34) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
95 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
95 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
96 2010 Survey/reported WHO/UNICEF
97 2009 Survey/reported WHO/UNICEF
95 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
93 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
82 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
95 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
94 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
95 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
90 1999 Survey/reported WHO/UNICEF
49 1998 Survey/reported WHO/UNICEF
97 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
145 (98 - 216) 2016 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.52 (2.04 - 3.09) 2019 Modelled IHME
2.52 (2.05 - 3.09) 2018 Modelled IHME
2.53 (2.06 - 3.11) 2017 Modelled IHME
2.57 (2.09 - 3.13) 2016 Modelled IHME
2.6 (2.12 - 3.19) 2015 Modelled IHME
2.59 (2.11 - 3.17) 2014 Modelled IHME
2.56 (2.10 - 3.12) 2013 Modelled IHME
2.53 (2.07 - 3.10) 2012 Modelled IHME
2.5 (2.05 - 3.05) 2011 Modelled IHME
2.49 (2.03 - 3.02) 2010 Modelled IHME
2.48 (2.03 - 3.02) 2009 Modelled IHME
2.48 (2.03 - 3.02) 2008 Modelled IHME
2.48 (2.03 - 3.02) 2007 Modelled IHME
2.47 (2.04 - 3.01) 2006 Modelled IHME
2.47 (2.03 - 3.02) 2005 Modelled IHME
2.46 (2.04 - 3) 2004 Modelled IHME
2.45 (2.02 - 2.98) 2003 Modelled IHME
2.44 (2.01 - 2.97) 2002 Modelled IHME
2.42 (1.99 - 2.96) 2001 Modelled IHME
2.42 (1.98 - 2.98) 2000 Modelled IHME
2.41 (1.97 - 2.95) 1999 Modelled IHME
2.41 (1.96 - 2.95) 1998 Modelled IHME
2.41 (1.96 - 2.96) 1997 Modelled IHME
2.4 (1.95 - 2.95) 1996 Modelled IHME
2.4 (1.93 - 2.96) 1995 Modelled IHME
2.39 (1.93 - 2.92) 1994 Modelled IHME
2.38 (1.92 - 2.92) 1993 Modelled IHME
2.36 (1.90 - 2.88) 1992 Modelled IHME
2.34 (1.88 - 2.87) 1991 Modelled IHME
2.32 (1.87 - 2.84) 1990 Modelled IHME
2.8 (1.90 - 3.20) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.3 (1 - 6.70) 2014 Survey/reported Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
58.5 (54 - 63.60) 2005 Modelled Nelson P et al, 2011
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
380,434 (305,755 - 465,548) 1990 Modelled IHME
382,046 (306,365 - 467,756) 1991 Modelled IHME
382,248 (307,548 - 465,179) 1992 Modelled IHME
381,159 (307,373 - 468,064) 1993 Modelled IHME
378,868 (305,945 - 463,194) 1994 Modelled IHME
375,526 (301,523 - 462,545) 1995 Modelled IHME
371,679 (301,304 - 456,588) 1996 Modelled IHME
368,096 (299,632 - 452,533) 1997 Modelled IHME
365,171 (296,892 - 446,498) 1998 Modelled IHME
363,225 (296,655 - 444,565) 1999 Modelled IHME
362,486 (296,964 - 447,101) 2000 Modelled IHME
363,287 (298,672 - 444,163) 2001 Modelled IHME
365,668 (301,608 - 445,432) 2002 Modelled IHME
369,112 (304,866 - 449,443) 2003 Modelled IHME
373,128 (308,759 - 455,188) 2004 Modelled IHME
377,204 (310,645 - 461,458) 2005 Modelled IHME
381,324 (313,939 - 463,613) 2006 Modelled IHME
385,905 (316,230 - 470,941) 2007 Modelled IHME
391,020 (320,833 - 477,053) 2008 Modelled IHME
396,700 (324,348 - 483,476) 2009 Modelled IHME
402,840 (328,290 - 490,013) 2010 Modelled IHME
411,217 (336,888 - 501,158) 2011 Modelled IHME
421,926 (345,303 - 516,149) 2012 Modelled IHME
433,510 (354,502 - 527,901) 2013 Modelled IHME
444,559 (362,367 - 544,694) 2014 Modelled IHME
453,116 (368,391 - 555,654) 2015 Modelled IHME
454,233 (369,848 - 552,413) 2016 Modelled IHME
453,869 (368,935 - 556,472) 2017 Modelled IHME
457,852 (372,354 - 561,313) 2018 Modelled IHME
462,700 (374,979 - 568,753) 2019 Modelled IHME
508,000 (334,000 - 572,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.51 (7.08 - 12.60) 2019 Modelled IHME
9.64 (7.38 - 12.60) 2018 Modelled IHME
9.78 (7.62 - 12.60) 2017 Modelled IHME
10 (7.83 - 13) 2016 Modelled IHME
10.3 (8.05 - 13.40) 2015 Modelled IHME
10.6 (8.37 - 13.70) 2014 Modelled IHME
11.1 (8.68 - 14.20) 2013 Modelled IHME
11.7 (9.25 - 14.90) 2012 Modelled IHME
11.4 (8.99 - 14.50) 2011 Modelled IHME
10.9 (8.69 - 13.80) 2010 Modelled IHME
10.3 (8.23 - 13) 2009 Modelled IHME
10.1 (8.12 - 12.80) 2008 Modelled IHME
10 (7.99 - 12.70) 2007 Modelled IHME
9.66 (7.66 - 12.20) 2006 Modelled IHME
9.27 (7.41 - 11.70) 2005 Modelled IHME
8.87 (7.10 - 11.20) 2004 Modelled IHME
8.51 (6.83 - 10.70) 2003 Modelled IHME
8.07 (6.49 - 10.10) 2002 Modelled IHME
7.77 (6.27 - 9.68) 2001 Modelled IHME
7.47 (6.03 - 9.27) 2000 Modelled IHME
7.22 (5.81 - 8.88) 1999 Modelled IHME
7.2 (5.78 - 8.79) 1998 Modelled IHME
7.2 (5.79 - 8.86) 1997 Modelled IHME
7.07 (5.65 - 8.70) 1996 Modelled IHME
6.68 (5.32 - 8.27) 1995 Modelled IHME
6.06 (4.83 - 7.53) 1994 Modelled IHME
5.41 (4.31 - 6.69) 1993 Modelled IHME
4.65 (3.71 - 5.71) 1992 Modelled IHME
3.99 (3.24 - 4.96) 1991 Modelled IHME
3.33 (2.67 - 4.19) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1,750 (1,302 - 2,323) 2019 Modelled IHME
1,751 (1,340 - 2,289) 2018 Modelled IHME
1,752 (1,365 - 2,260) 2017 Modelled IHME
1,773 (1,383 - 2,292) 2016 Modelled IHME
1,798 (1,401 - 2,326) 2015 Modelled IHME
1,827 (1,437 - 2,359) 2014 Modelled IHME
1,870 (1,468 - 2,406) 2013 Modelled IHME
1,948 (1,543 - 2,491) 2012 Modelled IHME
1,880 (1,477 - 2,391) 2011 Modelled IHME
1,774 (1,407 - 2,240) 2010 Modelled IHME
1,651 (1,316 - 2,081) 2009 Modelled IHME
1,601 (1,280 - 2,024) 2008 Modelled IHME
1,566 (1,246 - 1,980) 2007 Modelled IHME
1,488 (1,180 - 1,886) 2006 Modelled IHME
1,415 (1,131 - 1,780) 2005 Modelled IHME
1,343 (1,076 - 1,692) 2004 Modelled IHME
1,282 (1,029 - 1,607) 2003 Modelled IHME
1,211 (974 - 1,513) 2002 Modelled IHME
1,164 (939 - 1,451) 2001 Modelled IHME
1,121 (905 - 1,390) 2000 Modelled IHME
1,088 (875 - 1,338) 1999 Modelled IHME
1,091 (876 - 1,332) 1998 Modelled IHME
1,101 (885 - 1,354) 1997 Modelled IHME
1,093 (874 - 1,345) 1996 Modelled IHME
1,045 (832 - 1,293) 1995 Modelled IHME
960 (766 - 1,193) 1994 Modelled IHME
867 (690 - 1,071) 1993 Modelled IHME
752 (601 - 924) 1992 Modelled IHME
651 (527 - 808) 1991 Modelled IHME
545 (437 - 686) 1990 Modelled IHME
1,754 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
33 (24 - 43) 2019 Modelled IHME
34 (25 - 43) 2018 Modelled IHME
34 (25 - 44) 2017 Modelled IHME
34 (25 - 43) 2016 Modelled IHME
34 (25 - 43) 2015 Modelled IHME
34 (25 - 43) 2014 Modelled IHME
34 (25 - 43) 2013 Modelled IHME
34 (25 - 43) 2012 Modelled IHME
34 (25 - 43) 2011 Modelled IHME
34 (25 - 43) 2010 Modelled IHME
34 (25 - 43) 2009 Modelled IHME
33 (25 - 42) 2008 Modelled IHME
33 (24 - 42) 2007 Modelled IHME
33 (24 - 41) 2006 Modelled IHME
32 (23 - 41) 2005 Modelled IHME
32 (23 - 41) 2004 Modelled IHME
31 (22 - 40) 2003 Modelled IHME
31 (22 - 40) 2002 Modelled IHME
30 (22 - 39) 2001 Modelled IHME
30 (21 - 39) 2000 Modelled IHME
30 (21 - 39) 1999 Modelled IHME
30 (21 - 39) 1998 Modelled IHME
30 (21 - 39) 1997 Modelled IHME
30 (21 - 39) 1996 Modelled IHME
30 (21 - 39) 1995 Modelled IHME
30 (21 - 39) 1994 Modelled IHME
30 (22 - 39) 1993 Modelled IHME
31 (22 - 40) 1992 Modelled IHME
31 (23 - 40) 1991 Modelled IHME
33 (24 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
145 (98 - 216) 2016 Survey/reported Larney S et al, 2017
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
1,337
2019
(969 - 1,809)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,750
2019
(1,302 - 2,323)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
93 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
145
2016
(98 - 216)
Larney S et al, 2017
Eligible for HBV generic medicines
Eligible for HCV generic medicines